Gloger K
Arzneimittelforschung. 1975 Aug;25(8):1300-3.
In 21 healthy male persons haemodynamic changes (heart rate, end-diastolic pulmonary artery pressure, training condition of heart, a so-called index of heart sufficiency and arterial blood pressure) at rest and during dynamic exercise were compared respectively before and after i.v. injection of 0.0375 mg/kg of the beta-adrenergic blocking drug K+5Ao 1366 [O-(2-hydroxy-3-(tert. butylamino)-propoxy)-benzonitril-hydrochloride], of 0.3 mg/kg practolol [4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide] and a placebo. According to the analysed parameters Kö 1366 has an essentially better beta-adrenergic blocking potency than practolol. Neither of the two substances has a negative inotropic effect or influences the arterial blood pressure.
在21名健康男性中,分别比较了静脉注射0.0375毫克/千克的β-肾上腺素能阻滞剂K+5Ao 1366 [O-(2-羟基-3-(叔丁基氨基)-丙氧基)-苄腈盐酸盐]、0.3毫克/千克的心得宁[4-(2-羟基-3-异丙氨基丙氧基)-乙酰苯胺]和安慰剂前后,静息及动态运动时的血流动力学变化(心率、舒张末期肺动脉压、心脏训练状态,即所谓的心脏功能指数和动脉血压)。根据分析参数,Kö 1366的β-肾上腺素能阻滞效力明显优于心得宁。这两种物质均无负性肌力作用,也不影响动脉血压。